An article in the November 20, 2008 edition of the New England Journal of Medicine reports the results from a large, randomized study designed to assess the relationship between statin treatment and cardiovascular disease (as indicated by having at least one of several clinical endpoints). The researchers randomized 17,800 healthy (without a history of cardiovascular disease) men and women with non- elevated LDL cholesterol levels to either 20 mg of statins daily, or placebo. Subjects were followed for up to 5 years. At the end of the follow-up period the study results included the following: Of the 8900 subjects randomized to the statins group, 142 developed cardiovascular disease. Of the 8900 subjects randomized to the placebo group, 251 developed cardiovascular disease. (Reference: Ridker P, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. New England Journal of Medicine. (2008). 359;21) What is the estimated relative risk of developing cardiovascular disease for subjects in the statins group compared to subjects on placebo? The estimated relative risk is approximately - 0.012. O The estimated relative risk is approximately 1.77 O The estimated relative risk is approximately 0.57. The estimated relative risk is approximately 0.012.
An article in the November 20, 2008 edition of the New England Journal of Medicine reports the results from a large, randomized study designed to assess the relationship between statin treatment and cardiovascular disease (as indicated by having at least one of several clinical endpoints). The researchers randomized 17,800 healthy (without a history of cardiovascular disease) men and women with non- elevated LDL cholesterol levels to either 20 mg of statins daily, or placebo. Subjects were followed for up to 5 years. At the end of the follow-up period the study results included the following: Of the 8900 subjects randomized to the statins group, 142 developed cardiovascular disease. Of the 8900 subjects randomized to the placebo group, 251 developed cardiovascular disease. (Reference: Ridker P, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. New England Journal of Medicine. (2008). 359;21) What is the estimated relative risk of developing cardiovascular disease for subjects in the statins group compared to subjects on placebo? The estimated relative risk is approximately - 0.012. O The estimated relative risk is approximately 1.77 O The estimated relative risk is approximately 0.57. The estimated relative risk is approximately 0.012.
Holt Mcdougal Larson Pre-algebra: Student Edition 2012
1st Edition
ISBN:9780547587776
Author:HOLT MCDOUGAL
Publisher:HOLT MCDOUGAL
Chapter11: Data Analysis And Probability
Section: Chapter Questions
Problem 8CR
Related questions
Question
100%
its public health statistics only answer needed
Transcribed Image Text:7. An article in the November 20, 2008 edition of the New England Journal of Medicine reports the results from a large,
randomized study designed to assess the relationship between statin treatment and cardiovascular disease (as indicated
by having at least one of several clinical endpoints).
The researchers randomized 17,800 healthy (without a history of cardiovascular disease) men and women with non-
elevated LDL cholesterol levels to either 20 mg of statins daily, or placebo. Subjects were followed for up to 5 years. At the
end of the follow-up period the study results included the following:
Of the 8900 subjects randomized to the statins group, 142 developed cardiovascular disease. Of the 8900 subjects
randomized to the placebo group, 251 developed cardiovascular disease.
(Reference: Ridker P, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein.
New England Journal of Medicine. (2008). 359;21)
What is the estimated relative risk of developing cardiovascular disease for subjects in the statins group
compared to subjects on placebo?
The estimated relative risk is approximately - 0.012.
The estimated relative risk is approximately 1.77
The estimated relative risk is approximately 0.57.
The estimated relative risk is approximately 0.012.
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 2 steps
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, statistics and related others by exploring similar questions and additional content below.Recommended textbooks for you
Holt Mcdougal Larson Pre-algebra: Student Edition…
Algebra
ISBN:
9780547587776
Author:
HOLT MCDOUGAL
Publisher:
HOLT MCDOUGAL
Calculus For The Life Sciences
Calculus
ISBN:
9780321964038
Author:
GREENWELL, Raymond N., RITCHEY, Nathan P., Lial, Margaret L.
Publisher:
Pearson Addison Wesley,
Glencoe Algebra 1, Student Edition, 9780079039897…
Algebra
ISBN:
9780079039897
Author:
Carter
Publisher:
McGraw Hill
Holt Mcdougal Larson Pre-algebra: Student Edition…
Algebra
ISBN:
9780547587776
Author:
HOLT MCDOUGAL
Publisher:
HOLT MCDOUGAL
Calculus For The Life Sciences
Calculus
ISBN:
9780321964038
Author:
GREENWELL, Raymond N., RITCHEY, Nathan P., Lial, Margaret L.
Publisher:
Pearson Addison Wesley,
Glencoe Algebra 1, Student Edition, 9780079039897…
Algebra
ISBN:
9780079039897
Author:
Carter
Publisher:
McGraw Hill
College Algebra (MindTap Course List)
Algebra
ISBN:
9781305652231
Author:
R. David Gustafson, Jeff Hughes
Publisher:
Cengage Learning
